Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis.
Decreased regenerative capacity of oligodendrocyte progenitor cells (NG2-glia) in the ageing brain: a vicious cycle of synaptic dysfunction, myelin loss and neuronal disruption?
Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway.
Rosuvastatin enhances anti-inflammatory and inhibits pro-inflammatory functions in cultured microglial cells.
Serum ethanolamine plasmalogens improve detection of cognitive impairment among elderly with high excretion levels of urinary myo-inositol: A cross-sectional study.
Association study of four polymorphisms in the interleukin-7 receptor alpha gene with multiple sclerosis in Eastern Iran.
The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2(+) Monocytes and Licenses Autoimmunity.
Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases.
The Cellular Prion Protein: A Player in Immunological Quiescence.
Recurrent Optic Neuritis in Children.
A case of tumor-like inflammatory demyelinating disease with progressive brain and spinal cord involvement.
Stride-Time Variability and Fall Risk in Persons with Multiple Sclerosis.
Chronic constipation and co-morbidities: A prospective population-based nested case-control study.
Endocannabinoids and Endocannabinoid-Related Mediators: Targets, Metabolism and Role In Neurological Disorders.
Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
EBV & HHV6 reactivation is infrequent and not associated with MS clinical course.
Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions.
Enhanced patient support services improve patient persistence with multiple sclerosis treatment.
Ontogeny and Functions of Central Nervous System Macrophages.
Can we predict the evolution of an unpredictable disease like multiple sclerosis?
[The effect of tobacco smoking on clinical effectiveness of immunomodulatory treatment in multiple sclerosis patients].
Amino Acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors.
Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
Current management of relapsing-remitting multiple sclerosis.
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?

Pages